Centaurus Financial Inc. Takes Position in Cigna Group $CI

Posted by Stanley Muller on Aug 29th, 2026

Centaurus Financial Inc. purchased a new stake in Cigna Group (NYSE:CI – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,975 shares of the health services provider’s stock, valued at approximately $544,000.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Wilkerson Advisory Group LLC bought a new position in shares of Cigna Group in the fourth quarter worth about $25,000. Osbon Capital Management LLC bought a new stake in shares of Cigna Group during the second quarter valued at approximately $26,000. Kemnay Advisory Services Inc. bought a new stake in shares of Cigna Group during the fourth quarter valued at approximately $29,000. Prosperity Bancshares Inc acquired a new stake in shares of Cigna Group in the fourth quarter valued at approximately $29,000. Finally, Cedar Mountain Advisors LLC raised its position in Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after purchasing an additional 68 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Activity

In other news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 23,012 shares of company stock worth $6,386,550 in the last three months. Insiders own 0.60% of the company’s stock.

Cigna Group Price Performance

Shares of CI stock opened at $278.89 on Friday. The firm’s 50 day moving average price is $283.52 and its two-hundred day moving average price is $281.39. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The stock has a market cap of $73.69 billion, a PE ratio of 11.54, a PEG ratio of 0.96 and a beta of 0.29.

Cigna Group (NYSE:CI – Get Free Report) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. The company had revenue of $70.04 billion during the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, analysts forecast that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 25.82%.

Wall Street Analyst Weigh In

Several research firms have issued reports on CI. Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their price objective for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Deutsche Bank Aktiengesellschaft cut Cigna Group from a “buy” rating to a “hold” rating and lowered their target price for the company from $303.00 to $302.00 in a research note on Wednesday, May 20th. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 price target on shares of Cigna Group in a research note on Tuesday, June 16th. Piper Sandler decreased their price target on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Finally, Cantor Fitzgerald lifted their price objective on Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a research report on Friday, May 1st. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $339.45.

Check Out Our Latest Research Report on Cigna Group

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.